(Q35147057)

6 August 2017

Current management strategies for coexisting diabetes mellitus and obesity (English)

1 reference

6 August 2017

0 references

Andre J Scheen

1

1 reference

6 August 2017

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

63

1 reference

6 August 2017

1165-1184

1 reference

6 August 2017

12

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200363120-00001

6 August 2017

0 references

cites work

Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200363120-00001

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200363120-00001

Management of hypertension in patients with type 2 diabetes mellitus: guidelines based on current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200363120-00001

Diabetes, hypertension, and cardiovascular disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200363120-00001

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200363120-00001

Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.

21 January 2018

1 reference

12 December 2020

Is Type II Diabetes Mellitus (NIDDM) a Surgical Disease?

1 reference

12 December 2020

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

1 reference

12 December 2020

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

1 reference

12 December 2020

Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

1 reference

12 December 2020

Current status of medical and surgical therapy for obesity

1 reference

12 December 2020

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of orlistat in the management of obesity

1 reference

12 December 2020

Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study

1 reference

12 December 2020

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

Added benfluorex in obese insulin-requiring type 2 diabetes.

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Sibutramine. A review of its contribution to the management of obesity.

1 reference

12 December 2020

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

1 reference

12 December 2020

The importance of obesity in diabetes and its treatment with sibutramine

1 reference

12 December 2020

Antiobesity pharmacotherapy in the management of type 2 diabetes

1 reference

12 December 2020

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

1 reference

12 December 2020

Pharmacological treatment of the obese diabetic patient

1 reference

12 December 2020

Blood glucose control and insulin secretion improved with combined therapy in type 2 diabetic patients with secondary failure to oral hypoglycaemic agents.

1 reference

12 December 2020

The Safety and Efficacy of a Controlled Low-Energy ('Very-Low-Calorie') Diet in the Treatment of Non-Insulin-Dependent Diabetes and Obesity

1 reference

12 December 2020

Benefits and limitations of very-low-calorie diet therapy in obese NIDDM.

1 reference

12 December 2020

A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients

1 reference

12 December 2020

Benfluorex in obese noninsulin dependent diabetes mellitus patients poorly controlled by insulin: a double blind study versus placebo.

1 reference

12 December 2020

Stepwise and combination drug therapy for the treatment of NIDDM.

1 reference

12 December 2020

Meglitinide analogues in the treatment of type 2 diabetes mellitus

1 reference

12 December 2020

Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin

1 reference

12 December 2020

Guidelines for healthy weight

1 reference

12 December 2020

1 reference

12 December 2020

Pramlintide: an agent for glycemic control plus weight control?

1 reference

12 December 2020

Biliopancreatic diversion

1 reference

12 December 2020

Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.

1 reference

12 December 2020

Long-term effects of modest weight loss in type II diabetic patients.

1 reference

12 December 2020

Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial

1 reference

12 December 2020

Treating obesity in type 2 diabetes. Calories, composition, and control

1 reference

12 December 2020

Pharmacologic induction of weight loss to treat type 2 diabetes.

1 reference

12 December 2020

Very Low Calorie Diets: Their Efficacy, Safety, and Future

1 reference

12 December 2020

Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group

1 reference

12 December 2020

Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial

1 reference

12 December 2020

Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetes

1 reference

12 December 2020

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

12 December 2020

Effect of insulin therapy on blood pressure in NIDDM patients with secondary failure

1 reference

12 December 2020

Efficacy and safety of pioglitazone in type 2 diabetes: a randomised, placebo-controlled study in patients receiving stable insulin therapy

1 reference

12 December 2020

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.

1 reference

12 December 2020

Beneficial health effects of modest weight loss

1 reference

12 December 2020

The comparison of four weight reduction strategies aimed at overweight diabetic patients.

1 reference

12 December 2020

Sulfonylureas in NIDDM.

1 reference

12 December 2020

Dietary treatment and long-term weight loss and maintenance in type 2 diabetes

1 reference

12 December 2020

Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes

1 reference

12 December 2020

Role of sibutramine in the treatment of obese Type 2 diabetic patients receiving sulphonylurea therapy

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Promoting weight loss in type II diabetes.

1 reference

12 December 2020

Therapeutic effect of benfluorex in type II diabetic patients on diet regimen alone.

1 reference

12 December 2020

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

12 December 2020

American College of Sports Medicine position stand. Exercise and type 2 diabetes.

1 reference

12 December 2020

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients

1 reference

12 December 2020

1 reference

12 December 2020

Orlistat: in the prevention and treatment of type 2 diabetes mellitus

1 reference

12 December 2020

Info-congress. Prevention of type 2 diabetes in obese patients: first results with orlistat in the XENDOS study

1 reference

12 December 2020

Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity

1 reference

12 December 2020

Antidiabetic drugs present and future: will improving insulin resistance benefit cardiovascular risk in type 2 diabetes mellitus?

1 reference

12 December 2020

Oral therapies for diabetic hyperglycemia

1 reference

12 December 2020

Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults.

1 reference

12 December 2020

Oral antidiabetic agents. A guide to selection

1 reference

12 December 2020

[Benfluorex (Mediator) and non-insulin-dependent diabetes]

1 reference

12 December 2020

1 reference

12 December 2020

The prevention and treatment of obesity. Application to type 2 diabetes

1 reference

12 December 2020

Acarbose improves glycemic control in overweight type 2 diabetic patients insufficiently treated with metformin

1 reference

12 December 2020

Pharmacological approaches for the treatment of obesity

1 reference

12 December 2020

Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women

1 reference

12 December 2020

Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus.

1 reference

12 December 2020

Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs

1 reference

12 December 2020

Addition of benfluorex to biguanide improves glycemic control in obese non-insulin-dependent diabetes: a double-blind study versus placebo

1 reference

12 December 2020

Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.

1 reference

12 December 2020

Obesity and disease management: effects of weight loss on comorbid conditions

1 reference

12 December 2020

Health care and health status and outcomes for patients with type 2 diabetes

1 reference

12 December 2020

Effect of metformin on food intake in obese subjects.

1 reference

12 December 2020

Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients.

1 reference

12 December 2020

A double-blind placebo-controlled trial evaluating the safety and efficacy of acarbose for the treatment of patients with insulin-requiring type II diabetes

1 reference

12 December 2020

Effects of benfluorex on insulin resistance and lipid metabolism in obese type II diabetic patients

1 reference

12 December 2020

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Optimising therapy for insulin-treated type 2 diabetes mellitus

1 reference

12 December 2020

A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes

1 reference

12 December 2020

Exercise alone is an effective strategy for reducing obesity and related comorbidities

1 reference

12 December 2020

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

12 December 2020

Diet and risk of Type II diabetes: the role of types of fat and carbohydrate

1 reference

12 December 2020

The pharmacological treatment of hyperglycemia in NIDDM. American Diabetes Association

1 reference

12 December 2020

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

12 December 2020

Lipid management in diabetic patients: lessons from prevention trials

1 reference

12 December 2020

Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors.

1 reference

12 December 2020

Pharmacological treatment of obesity: present status

1 reference

12 December 2020

Aggressive weight reduction treatment in the management of type 2 diabetes.

1 reference

12 December 2020

Orlistat in the treatment of Type 2 diabetes mellitus

1 reference

12 December 2020

1 reference

12 December 2020

[Benefits and limitations of protein diets in obese patients with type 2 diabetes]

1 reference

12 December 2020

Long-term efficacy of dietary treatment of obesity: a systematic review of studies published between 1931 and 1999.

1 reference

12 December 2020

Insulin resistance, hyperinsulinemia and diabetes--contribution of benfluorex. Prague, 11 September 1992. Symposium proceedings

1 reference

12 December 2020

Intentional weight loss and mortality among overweight individuals with diabetes.

1 reference

12 December 2020

Troglitazone reduces plasma leptin concentration but increases hunger in NIDDM patients

1 reference

12 December 2020

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

1 reference

12 December 2020

A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin

1 reference

12 December 2020

The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

1 reference

12 December 2020

Troglitazone prevents the rise in visceral adiposity and improves fatty liver associated with sulfonylurea therapy--a randomized controlled trial

1 reference

12 December 2020

Effect of rosiglitazone on insulin sensitivity and body composition in type 2 diabetic patients [corrected].

1 reference

12 December 2020

Regional adiposity and morbidity

1 reference

12 December 2020

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

12 December 2020

Implications of the United Kingdom prospective diabetes study for patients with obesity and type 2 diabetes

1 reference

12 December 2020

Combination therapies with insulin in type 2 diabetes

1 reference

12 December 2020

The benefits of modest weight loss in type II diabetes

1 reference

12 December 2020

Efficacy of metformin in the treatment of NIDDM. Meta-analysis

1 reference

12 December 2020

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.

1 reference

12 December 2020

Treatment of hypertension in patients with type-2 diabetes mellitus

1 reference

12 December 2020

Efficacy of troglitazone on body fat distribution in type 2 diabetes

1 reference

12 December 2020

Ramipril and the development of diabetes.

1 reference

12 December 2020

Effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control

1 reference

12 December 2020

Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials

1 reference

12 December 2020

Metabolic consequences of weight loss on glucose metabolism and insulin action in type 2 diabetes

1 reference

12 December 2020

Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus.

1 reference

12 December 2020

The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus.

1 reference

12 December 2020

Clinical efficacy of acarbose in diabetes mellitus: a critical review of controlled trials.

1 reference

12 December 2020

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

12 December 2020

Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study.

1 reference

12 December 2020

Influences on weight loss in type 2 diabetic patients: little long-term benefit from group behaviour therapy and exercise training.

1 reference

12 December 2020

Overweight, obesity, and health risk

1 reference

12 December 2020

Management of type 2 diabetes mellitus and cardiovascular risk: lessons from intervention trials

1 reference

12 December 2020

Intensive insulin therapy combined with metformin in obese type 2 diabetic patients.

1 reference

12 December 2020

Long-term glycaemic improvement after addition of metformin to insulin in insulin-treated obese type 2 diabetes patients

1 reference

12 December 2020

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

1 reference

12 December 2020

Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients

1 reference

12 December 2020

Minor long-term changes in weight have beneficial effects on insulin sensitivity and beta-cell function in obese subjects

1 reference

12 December 2020

Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes

1 reference

12 December 2020

Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus

1 reference

12 December 2020

A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity

1 reference

12 December 2020

New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat

1 reference

12 December 2020

Exercise in the management of non-insulin-dependent (type 2) diabetes mellitus

1 reference

12 December 2020

1 reference

12 December 2020

Acarbose improves indirectly both insulin resistance and secretion in obese type 2 diabetic patients.

1 reference

12 December 2020

Hypertension and diabetes: the scope of the problem

1 reference

12 December 2020

Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus.

1 reference

12 December 2020

Efficacy and safety of acarbose add-on therapy in the treatment of overweight patients with Type 2 diabetes inadequately controlled with metformin: a double-blind, placebo-controlled study.

1 reference

12 December 2020

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group

1 reference

12 December 2020

Diet and Exercise Among Adults With Type 2 Diabetes: Findings from the Third National Health and Nutrition Examination Survey (NHANES III)

1 reference

12 December 2020

The effects of orlistat on body weight and glycaemic control in overweight patients with type 2 diabetes: a randomized, placebo-controlled trial

1 reference

12 December 2020

A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)

1 reference

12 December 2020

Pharmacologic therapy for type 2 diabetes mellitus

1 reference

12 December 2020

Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s. Achievements and future developments

1 reference

12 December 2020

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

12 December 2020

An overview of metformin in the treatment of type 2 diabetes mellitus

1 reference

12 December 2020

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

12 December 2020

Glitazones and weight gain

1 reference

12 December 2020

Management of obesity in patients with Type 2 diabetes

1 reference

12 December 2020

1 reference

12 December 2020

Lifestyle modifications for diabetes management

1 reference

12 December 2020

Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding

1 reference

12 December 2020

Diet and exercise in type 2 diabetes mellitus

1 reference

12 December 2020

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women

1 reference

12 December 2020

The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study

1 reference

12 December 2020

The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish Multimorbidity Study

1 reference

12 December 2020

Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study.

1 reference

12 December 2020

Is There a Role for ??-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus?

1 reference

12 December 2020

The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. BIGPRO Study Group.

1 reference

12 December 2020

Therapeutic benefit of benfluorex in type II diabetic patients treated with sulfonylureas.

1 reference

12 December 2020

Combining insulin and oral agents

1 reference

12 December 2020

Type II diabetic subjects lose less weight than their overweight nondiabetic spouses.

1 reference

12 December 2020

Responsible and irresponsible use of very-low-calorie diets in the treatment of obesity

1 reference

12 December 2020

Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated subjects with type 2 diabetes

1 reference

12 December 2020

Sudden death associated with very low calorie weight reduction regimens

1 reference

12 December 2020

10.2165/00003495-200363120-00001

Identifiers

DOI

1 reference

PubMed ID

12790691

Dimensions Publication ID

6 August 2017

0 references

1 reference

PubMed ID

12790691